These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 18705308)
21. Predicting initial recurrence pattern of esophageal cancer after neoadjuvant chemotherapy. Tabira Y; Yasunaga M; Sakaguchi T; Nagamoto N; Ogi S; Kitamura N Hepatogastroenterology; 2000; 47(35):1315-8. PubMed ID: 11100340 [TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077 [TBL] [Abstract][Full Text] [Related]
23. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862 [TBL] [Abstract][Full Text] [Related]
24. A case report of advanced thoracic esophageal cancer with severe malignant stricture. Hanashi T; Ishii A; Ishizu K; Matsui H; Kondoh Y; Makuuchi H Tokai J Exp Clin Med; 2006 Dec; 31(4):167-9. PubMed ID: 21302249 [TBL] [Abstract][Full Text] [Related]
25. Toxicity of chemotherapy for esophageal carcinoma. Ilson D Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402 [TBL] [Abstract][Full Text] [Related]
26. [Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University]. Siewert JR; Bartels H; Bollschweiler E; Dittler HJ; Fink U; Hölscher AH; Roder JD Chirurg; 1992 Sep; 63(9):693-700. PubMed ID: 1382922 [No Abstract] [Full Text] [Related]
27. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Cao XF; He XT; Ji L; Xiao J; Lv J Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071 [TBL] [Abstract][Full Text] [Related]
28. [Histological effect and prognosis after preoperative chemotherapy in esophageal cancer]. Ohara M; Ishihara K; Abe T; Yamazaki S; Miura T; Tanabe Y; Kusano M; Okayasu T; Hosokawa M; Fujita M Rinsho Byori; 1995 Mar; 43(3):238-46. PubMed ID: 7745829 [TBL] [Abstract][Full Text] [Related]
30. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Rohatgi P; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh GL; Vaporciyan AA; Rice DC; Roth JA; Ajani JA Cancer; 2005 Dec; 104(11):2365-72. PubMed ID: 16245310 [TBL] [Abstract][Full Text] [Related]
31. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547 [TBL] [Abstract][Full Text] [Related]
32. Making sense of multimodality therapy for esophageal cancer. Krasna MJ; Mao YS Surg Oncol Clin N Am; 1999 Apr; 8(2):259-78. PubMed ID: 10339645 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. Kitamura K; Saeki H; Kawaguchi H; Araki K; Ohno S; Kuwano H; Maehara Y; Sugimachi K Hepatogastroenterology; 2000; 47(32):419-23. PubMed ID: 10791203 [TBL] [Abstract][Full Text] [Related]
36. [Neoadjuvant therapy in oesophageal cancer surgery]. Imdahl A Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Chen G; Wang Z; Liu XY; Liu FY Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580 [TBL] [Abstract][Full Text] [Related]
38. Implantation of self-expanding metallic stent for patients with malignant stricture after failure of definitive chemoradiotherapy for T3 or T4 esophageal squamous cell carcinomas. Kaneko K; Ito H; Konishi K; Kurahashi T; Katagiri A; Katayose K; Kitahara T; Ohtsu A; Mitamura K Hepatogastroenterology; 2002; 49(45):699-705. PubMed ID: 12063973 [TBL] [Abstract][Full Text] [Related]
39. [Results of surgical resection of squamous cells carcinoma of the oesophagus with or without preoperative radiochemotherapy: comparative and retrospective study]. Vandenbroucke F; Lozac'h P; Metges JP; Malhaire JP Ann Chir; 2004 Dec; 129(10):583-8. PubMed ID: 15581819 [TBL] [Abstract][Full Text] [Related]
40. [A case of squamous cell carcinoma of esophagus with mediastinal lymph node recurrence after surgical resection treated with systemic chemotherapy and chemoradiotherapy]. Matsuyama J; Fukushima Y; Hashimoto K; Morita S; Morimoto T; Nishishou I; Sasaki Y Gan To Kagaku Ryoho; 2007 Nov; 34(12):1991-2. PubMed ID: 18219875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]